Utah Medical Products' board of directors approved the share repurchase tender offer on September 15, 2026.
7 reports, 1 independent
Updated Thu 00:00
Mostly repetition
Reached 4 outlets in its first 24 hours
- Reports
- 7
- Developments
- 1
- Repetition
- 86%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Utah Medical Products' board of directors approved the share repurchase tender offer on September 15, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
board of directors
group of people who jointly supervise the activities of an organization
Related events
- The board of directors of a company increased its share repurchase authorization on September 10, 2026.
- A company authorized a share repurchase program of up to $100 million on August 1, 2026.
- A company's board of directors adopted a stock repurchase program on August 1, 2026, under a trading plan authorized under Rule 10b5-1.
- The board of directors of Orchid Island Capital, Inc. authorized a share buyback plan on July 1, 2026.
- A company's board of directors authorized management to repurchase company shares.